Videos and webinars
-
When To Shift To A Master Cell Bank
11/5/2026
In this segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” panelists Ted Peters, Ph.D., and Ronan O’Kennedy, Ph.D., answer audience questions pertaining to master cell banking (MCB) and technology transfer.
-
Exciting Advances In Cell Line Development
11/5/2026
In this segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” panelists Ted Peters, Ph.D., and Ronan O’Kennedy, Ph.D., discuss the trends or advancements that excite them the most, which include a deeper understanding of CHO cell biology and the industry-wide push towards continuous manufacturing.
-
Clone Selection And CMC Documentation
11/5/2026
This closing segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” focuses on clone selection and the regulatory importance of demonstrating clonality in cell line development (CLD). Panelists Ted Peters, Ph.D., and Ronan O’Kennedy, Ph.D., also share their thoughts on Operation Trial Blazer.
-
Overlooked Aspects Of Cell Line Development
11/5/2026
This opening segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” features panelists Ted Peters, Ph.D., head of cell line development at Immunome, and Ronan O’Kennedy, Ph.D., from ROK Bioconsulting. Peters and O’Kennedy begin by talking about the areas of cell line development they feel are often overlooked, including the alignment of early-stage work with later-stage work.
-
Properly Documenting Early Cell Line Development
11/5/2026
In this segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” panelists Ted Peters, Ph.D., and Ronan O’Kennedy, Ph.D., agree that documentation (or rather, failing to document) is the most common issue they’ve encountered teams make in cell line development (CLD). They both believe teams should spend more time correctly documenting early CLD and understanding regulatory requirements ahead of IND submission.
-
Cell Line Platform Selection
11/5/2026
In this segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” panelists Ted Peters, Ph.D., and Ronan O’Kennedy, Ph.D., explore the nuances and considerations surrounding cell line selection, as well as discuss when it’s appropriate to move from transient systems into stable GMP cell lines.
-
Ensuring Stability In Cell Lines
11/5/2026
In this segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” panelists Ted Peters, Ph.D., and Ronan O’Kennedy, Ph.D., discuss the importance of stability in cell lines and how our understanding of this has changed over time.
-
Introducing The Next Revolution In Sterile Disconnect Technology
7/20/2026
Streamline downstream bioprocess teardown with high-flow, non-spill disconnect solutions designed to resist harsh chemicals and protect closed system fluid lines.
-
Streamline Fluid Disconnections And Reduce Tear-Down Complexity
7/5/2026
Accelerate process turnover and fortify fluid line sterility without complex tools. Gain insight into how modern, metal-free connector geometries mitigate spillage and preserve cell viability.
-
Maintaining Closed Systems With Intrinsic Sterile Connections
5/13/2026
Watch this tech expo video to learn how intrinsic sterile connection devices maintain critical closed-system integrity and support Annex 1 compliance.